Alzheimer's & dementia (New York, N. Y.) - JoVE Visualize

Showing results (241-250 of 1,061) with videos related to

Pageof 107

Sort By:

Alzheimer'S & Dementia (New York, N. Y.)|June 8, 2026

Worth their weight in gray matter? A narrative review of cost-effectiveness analyses of monoclonal antibodies for Alzheimer's diseaseTuyet Thao Nguyen, Bozhidar T Chakalov, Megan Van Noord, et al.

Alzheimer'S & Dementia (New York, N. Y.)|May 7, 2026

Alzheimer's disease drug development pipeline: 2026Jeffrey L Cummings, Yadi Zhou, Yuxin Yang, et al.

Alzheimer'S & Dementia (New York, N. Y.)|February 7, 2019

The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine-A randomized, double-blind, placebo-controlled trialChristopher L H Chen, Purabi Reang Sharma, Boon Yeow Tan, et al.

Alzheimer'S & Dementia (New York, N. Y.)|July 29, 2026

Pharmacodynamic and stage-dependent therapeutic efficacy of SFRP1 neutralization in a mouse model of Alzheimer's diseasePablo Miaja, Marcos Martinez-Baños, María Jesús Martin-Bermejo, et al.

Alzheimer'S & Dementia (New York, N. Y.)|July 22, 2026

The proteomic and metabolomic signature of inherited chromosomally integrated HHV-6 and its role in all-cause dementia and mortality risk: The UK Biobank studyMay A Beydoun, Minkyo Song, Choa Yun, et al.

Alzheimer'S & Dementia (New York, N. Y.)|August 12, 2026

Differential presence of cerebral microbleeds in an amyloid mouse model compared with a CADASIL mouse modelXiuli Yang, Yuguo Li, Adnan Bibic, et al.

Alzheimer'S & Dementia (New York, N. Y.)|August 7, 2026

The moderating effect of dietary fiber and protein on the relationship between symptoms of depression and anxiety and cognitive declineSamantha L Gardener, Hilal Salim Said Al Shamsi, Stephanie R Rainey-Smith, et al.

Alzheimer'S & Dementia (New York, N. Y.)|August 23, 2026

Sex- and APOE-specific transcriptomic drug repurposing identifies four candidate therapeutics for Alzheimer's diseaseFrancesca Vitali, Adam C Raikes, Simona Merlini, et al.

Alzheimer'S & Dementia (New York, N. Y.)|September 9, 2026

Correlations of PSEN1, PSEN2, and APP missense variants on the production of Aβ peptides against variant effect predictionJiyeon Song, Serina Yan, Sophia Liu, et al.

Alzheimer'S & Dementia (New York, N. Y.)|September 10, 2026

Remote digital cognitive assessment in a trial-ready Alzheimer's disease cohort: A scalable approach for early intervention studiesAndrew J Aschenbrenner, Hannah Wilks, Matthew Welhaf, et al.

Pageof 107

Showing results (241-250 of 1,061) with videos related to

Sort By:

Pageof 107

Alzheimer'S & Dementia (New York, N. Y.)|June 8, 2026

Worth their weight in gray matter? A narrative review of cost-effectiveness analyses of monoclonal antibodies for Alzheimer's diseaseTuyet Thao Nguyen, Bozhidar T Chakalov, Megan Van Noord, et al.

Alzheimer'S & Dementia (New York, N. Y.)|May 7, 2026

Alzheimer's disease drug development pipeline: 2026Jeffrey L Cummings, Yadi Zhou, Yuxin Yang, et al.

Alzheimer'S & Dementia (New York, N. Y.)|February 7, 2019

The Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine-A randomized, double-blind, placebo-controlled trialChristopher L H Chen, Purabi Reang Sharma, Boon Yeow Tan, et al.

Alzheimer'S & Dementia (New York, N. Y.)|July 29, 2026

Pharmacodynamic and stage-dependent therapeutic efficacy of SFRP1 neutralization in a mouse model of Alzheimer's diseasePablo Miaja, Marcos Martinez-Baños, María Jesús Martin-Bermejo, et al.

Alzheimer'S & Dementia (New York, N. Y.)|July 22, 2026

The proteomic and metabolomic signature of inherited chromosomally integrated HHV-6 and its role in all-cause dementia and mortality risk: The UK Biobank studyMay A Beydoun, Minkyo Song, Choa Yun, et al.

Alzheimer'S & Dementia (New York, N. Y.)|August 12, 2026

Differential presence of cerebral microbleeds in an amyloid mouse model compared with a CADASIL mouse modelXiuli Yang, Yuguo Li, Adnan Bibic, et al.

Alzheimer'S & Dementia (New York, N. Y.)|August 7, 2026

The moderating effect of dietary fiber and protein on the relationship between symptoms of depression and anxiety and cognitive declineSamantha L Gardener, Hilal Salim Said Al Shamsi, Stephanie R Rainey-Smith, et al.

Alzheimer'S & Dementia (New York, N. Y.)|August 23, 2026

Sex- and APOE-specific transcriptomic drug repurposing identifies four candidate therapeutics for Alzheimer's diseaseFrancesca Vitali, Adam C Raikes, Simona Merlini, et al.

Alzheimer'S & Dementia (New York, N. Y.)|September 9, 2026

Correlations of PSEN1, PSEN2, and APP missense variants on the production of Aβ peptides against variant effect predictionJiyeon Song, Serina Yan, Sophia Liu, et al.

Alzheimer'S & Dementia (New York, N. Y.)|September 10, 2026

Remote digital cognitive assessment in a trial-ready Alzheimer's disease cohort: A scalable approach for early intervention studiesAndrew J Aschenbrenner, Hannah Wilks, Matthew Welhaf, et al.

Pageof 107